Monthly Archives: December 2013

Uganda Parliament passes Anti Homosexuality bill, “filling gaps,” adding further blows to HIV response

By on .

Substituting life in prison for the death penalty as the punishment for “aggravated homosexuality,” the Ugandan Parliament passed its Anti Homosexuality Bill today, filling “gaps,” it says, in existing law. While a text of the current bill is not available, “aggravated homosexuality,”  under the 2009 bill includes being a “serial offender” or being an “offender” […]

The Year in Global Health: Top 10 stories in HIV, TB around the world

By on .

HIV, TB research, funding, policy developments, setbacks of 2013 lay out promises and challenges for 2014 The PEPFAR Stewardship and Oversight Act – In a year when Congress couldn’t even keep the Panda-cam on, expectations for the future of the legislation that launched PEPFAR and that was set to expire this year were low. The […]

International AIDS Society to India: Return of anti-gay law a “major setback” to country’s HIV response

By on .

Within the week that India’s Supreme Court reinstated the nation’s colonial-era anti-sodomy law, a letter from the International AIDS Society has counted the ways the decision brings harm to the country, its sexual minority populations, its response to its HIV/AIDS epidemics, and to other Commonwealth nations, for which, during the last four years, India had […]

Dr. Robert Gallo on HIV, Polio, Influenza and why he started the Global Virus Network: “Humans have a memory span of 30 years, and I can prove it”

By on .

Listening to Robert Gallo talk about viruses is a little like listening to your grandfather talk about how things have changed since he was a boy. He rambles, ruminates, digresses, is in no hurry, and you listen. It’s not just that Gallo, who pioneered the field of retrovirology at the National Institutes of Health with […]

HIV stigma reduction should be at core of global HIV response, say panelists

By on .

When Regan Hoffman first moved to Washington D.C., she was asked by a potential landlord why she worked in HIV/AIDS advocacy.  Fearing discrimination, she hesitated before saying that she works in HIV advocacy because she’s infected with the disease herself.  Her landlord said he didn’t care about her status, and she breathed a sigh of […]

Ukraine anti-corruption report examines how HIV and TB drug procurement loopholes feed epidemics

By on .

Living amidst one of the fastest growing HIV epidemics in Europe, with among the highest rates of both HIV and TB, one in eight people living with HIV in Ukraine also has tuberculosis and one in eight living with HIV dies, according to a report from, the country’s Anti-corruption Action Centre, and All Ukrainian Network […]

Tuberculosis drug maker Sanofi drops price, easing access to shortened TB infection treatment

By on .

It was Christmas come early for publicly funded TB programs and for advocates of improved tuberculosis regimens when the maker of a rifapentine, a drug that can shorten treatment for tuberculosis infection from as much as nine months to three months announced Thursday it will drop its price for the medicine to a dollar a […]

Global donors’ shortfalls, South Africa stockouts, India’s gay rights reversal, and One’s report: We’re reading about how to snatch defeat from the jaws of victory, and vice versa

By on .

The Toll from Three Deadly Diseases – This New York Times editorial notes the gap shown in the just released World Health Organization report on malaria between progress against the disease and what could be accomplished with adequate funding. AIDS and Tuberculosis data have shown similar patterns, the editorial says. The numbers add up to […]

HIV, TB, Malaria and other infectious diseases raise demand for new diagnostic tools

By on .

The sudden fever that a Ugandan farmer fell ill with could have been a death sentence, as Beth Bell of the Centers for Disease Control and Prevention, described it at a Capitol Hill briefing last week. That’s because in rural Uganda, which Bell referred to as a “hot zone for emerging infectious diseases,” you can’t […]